| Microorganism |
|
|
|
| Antimicrobial |
 |
|
Reference |
| Staphylococcus aureus (community-associated + methicillin-resistant) |
0.12 |
0.25 |
0.06 － 1 |
Daptomycin (Cubicin) |
1376 |
| Staphylococcus aureus (community-associated + methicillin-resistant) |
0.12 |
8 |
≤0.12 － >8 |
Co-trimoxazole (Trimethoprim-sulfamethoxazole, TMP-SMX) |
1376 |
| Staphylococcus aureus (community-associated + methicillin-resistant) |
0.25 |
0.5 |
0.12 － 0.5 |
Tigecycline (GAR-936, Tigacyl) |
1376 |
| Staphylococcus aureus (community-associated + methicillin-resistant) |
1 |
1 |
≤0.25 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
1376 |
| Staphylococcus aureus (community-associated + methicillin-resistant) |
2 |
2 |
≤0.12 － 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
1376 |
| Staphylococcus aureus (community-associated + methicillin-resistant) |
>8 |
>8 |
≤0.25 － >8 |
Clindamycin (Cleocin) |
1376 |
| Staphylococcus aureus (community-associated + methicillin-resistant) |
>8 |
>16 |
≤0.06 － >16 |
Moxifloxacin (BAY 12-8039, Avelox) |
1376 |
| Staphylococcus aureus (community-associated + methicillin-resistant) |
>16 |
>16 |
0.25 － >16 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1376 |
| Staphylococcus aureus (community-associated + methicillin-resistant) |
>16 |
>16 |
≤0.25 － >16 |
Clarithromycin (Biaxin) |
1376 |
| Staphylococcus aureus (community-associated + methicillin-resistant) |
>32 |
>32 |
0.12 － >32 |
Levofloxacin (Levaquin, Quixin) |
1376 |
| Staphylococcus aureus (community-associated + methicillin-resistant) |
>128 |
>128 |
1 － >128 |
Cefazolin (Ancef, Kefzol, Zolicef) |
1376 |